1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 91 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010Genome-wide identification of human FOXP3 target genes in natural regulatory T cellsSadlon, T.; Wilkinson, B.; Pederson, S.; Brown, C.; Bresatz, S.; Gargett, T.; Melville, E.; Peng, K.; D'Andrea, R.; Glonek, G.; Goodall, G.; Zola, H.; Shannon, F.; Barry, S.
2018The osteoprogenitor-specific loss of ephrinB1 results in an osteoporotic phenotype affecting the balance between bone formation and resorptionArthur, A.; Nguyen, T.; Paton, S.; Klisuric, A.; Zannettino, A.; Gronthos, S.
2016Topical application of fingolimod perturbs cutaneous inflammationSun, W.Y.; Dimasi, D.P.; Pitman, M.R.; Zhuang, Y.; Heddle, R.; Pitson, S.M.; Grimbaldeston, M.A.; Bonder, C.S.
2015X-Ray fluorescence imaging and other analyses identify selenium and GPX1 as important in female reproductive functionCeko, M.; Hummitzsch, K.; Hatzirodos, N.; Bonner, W.; Aitken, J.; Russell, D.; Lane, M.; Rodgers, R.; Harris, H.
2014Identification of highly conserved putative developmental enhancers bound by SOX3 in neural progenitors using ChIP-SeqMcAninch, D.; Thomas, P.; Zheng, D.
2013Natural killer cell dependent within-host competition arises during multiple MCMV infection: consequences for viral transmission and evolutionMcWhorter, A.; Smith, L.; Masters, L.; Chan, B.; Shellam, G.; Redwood, A.; Mossman, K.L.
2013Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic painWang, X.; Grace, P.; Pham, M.; Cheng, K.; Strand, K.; Smith, C.; Li, J.; Watkins, L.; Yin, H.
2015Ectopic bone formation by mesenchymal stem cells derived from human term placenta and the deciduaKusuma, G.; Menicanin, D.; Gronthos, S.; Manuelpillai, U.; Abumaree, M.; Pertile, M.; Brennecke, S.; Kalionis, B.; Matsusaki, M.
2016Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4Wang, X.; Zhang, Y.; Peng, Y.; Hutchinson, M.; Rice, K.; Yin, H.; Watkins, L.
2015The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein RaiddPeintner, L.; Dorstyn, L.; Kumar, S.; Aneichyk, T.; Villunger, A.; Manzl, C.

Discover